Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension

Gastroenterology. 2000 Jul;119(1):196-200. doi: 10.1053/gast.2000.8554.

Abstract

Background & aims: In portal hypertension, the mechanisms responsible for nitric oxide (NO) overproduction and vasodilation have not yet been clearly identified. One hypothesis is that NO synthase (NOS) 3 is overactivated because of shear stress in endothelial cells caused by hyperkinetic circulation. The aim of this study was to evaluate aortic NOS3 after a reduction of blood flow by long-time beta-adrenoceptor antagonist administration.

Methods: Propranolol or atenolol was administered by gavage in portal vein-stenosed and sham-operated rats. The vascular reactivity of thoracic aortic rings to phenylephrine, total aortic NOS activity, and aortic NOS3 messenger RNA and protein expressions were studied.

Results: After propranolol or atenolol administration, the aortic hyporesponse returned to normal in portal vein-stenosed rats. Total aortic NOS activity was higher in portal vein-stenosed aortas and significantly decreased after beta-blocker administration. Aortic NOS3 expressions were more marked in portal vein-stenosed aortas than in controls, but NOS3 expressions were reduced after propranolol administration.

Conclusions: In portal hypertension, aortic NOS3 activity and expressions are enhanced but return to normal after beta-blocker administration. These results suggest that in portal hypertension, increased shear stress, related to high blood flow, induces enhanced aortic NOS3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Antihypertensive Agents / pharmacology
  • Aorta / enzymology*
  • Atenolol / pharmacology
  • Constriction, Pathologic
  • Hypertension, Portal / physiopathology*
  • In Vitro Techniques
  • Male
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / physiology*
  • Nitric Oxide Synthase Type III
  • Portal Vein / physiopathology
  • Propranolol / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reference Values
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • RNA, Messenger
  • Vasodilator Agents
  • Atenolol
  • Propranolol
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat